Long non-coding RNA-CTD-2108O9.1 represses breast cancer metastasis by influencing leukemia inhibitory factor receptor

Cancer Sci. 2018 Jun;109(6):1764-1774. doi: 10.1111/cas.13592. Epub 2018 Apr 28.

Abstract

Breast cancer (BC) is an aggressive malignant disease in women worldwide with a high tendency to metastasize. However, important biomarkers for BC metastasis remain largely undefined. In the present study, we identified that long non-coding RNA-CTD-2108O9.1 is downregulated in BC tissues and cells and acts as a metastatic inhibitor of BC. Mechanistic investigation determined that lncRNA-CTD-2108O9.1 represses metastasis by targeting leukemia inhibitory factor receptor (LIFR), which is designated as a metastasis suppressor in BC. Our study characterizes a significant tumor suppressor active in BC metastasis repression through the known metastasis inhibitor LIFR.

Keywords: EMT; LIFR; breast cancer; lncRNA; metastasis.

MeSH terms

  • Animals
  • Breast Neoplasms / genetics*
  • Breast Neoplasms / pathology
  • Cell Line
  • Cell Line, Tumor
  • Cell Movement / genetics
  • Female
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Lymphatic Metastasis
  • MCF-7 Cells
  • Mice, Inbred BALB C
  • Mice, Nude
  • Middle Aged
  • RNA Interference
  • RNA, Long Noncoding / genetics*
  • Receptors, OSM-LIF / genetics*
  • Transplantation, Heterologous

Substances

  • RNA, Long Noncoding
  • Receptors, OSM-LIF